Omeros corporation reports recovery and survival of all patients in study evaluating narsoplimab for treatment of covid-19-associated acute respiratory distress syndrome

Omeros corporation (nasdaq: omer) today reported the results of a compassionate-use study evaluating narsoplimab, omeros’ investigational human monocl

OMER Ratings Summary

OMER Quant Ranking